We compared the HR+ACC group with the HR+ACC group and found that there was no significant difference in clinicopathologic characteristics between the two groups, suggesting that perhaps a positive ER and PR status does not significantly affect the prognosis of the tumor. The gene discussed is PGR; the disease is neoplasm.